Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 1985 May;27(5):812-6.
doi: 10.1128/AAC.27.5.812.

Relationship between rat renal accumulation of gentamicin, tobramycin, and netilmicin and their nephrotoxicities

Relationship between rat renal accumulation of gentamicin, tobramycin, and netilmicin and their nephrotoxicities

M E Brier et al. Antimicrob Agents Chemother. 1985 May.

Abstract

Gentamicin, tobramycin, and netilmicin were given to rats in daily doses of either 5 or 20 mg/kg for 30 days to determine the renal accumulation kinetics of the compounds and to correlate steady-state renal parenchymal concentrations with nephrotoxicity. Four rats from each group were sacrificed daily and renal parenchymal tissue concentrations were determined microbiologically. Nephrotoxicity was assessed by changes in creatinine values in serum, renal creatinine clearances, and pathological scores. There was no indication of aminoglycoside-induced nephrotoxicity in any tests performed. The following steady-state levels resulted: 36, 148, and 176 micrograms/g after 5 mg/kg per day and 148, 260, and 510 micrograms/g after 20 mg/kg per day for tobramycin, gentamicin, and netilmicin, respectively. We conclude that aminoglycoside parenchymal accumulation in rats follows this order: tobramycin less than gentamicin less than netilmicin. Therefore, differences in the relative toxicities of gentamicin, tobramycin, and netilmicin do not correlate with the renal parenchymal accumulation of these agents and may be more dependent on intrinsic toxicity to the renal proximal tubule than to the concentration of the aminoglycoside in the kidney.

PubMed Disclaimer

References

    1. J Infect Dis. 1974 Dec;130(6):656-9 - PubMed
    1. Clin Pharmacol Ther. 1977 Sep;22(3):364-70 - PubMed
    1. J Pharmacokinet Biopharm. 1977 Dec;5(6):559-77 - PubMed
    1. Antimicrob Agents Chemother. 1978 Jan;13(1):34-40 - PubMed
    1. J Antimicrob Chemother. 1978 May;4 Suppl A:85-101 - PubMed

Publication types